Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplantAndrew A Lane, Philippe Armand, Yang Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
The Journal of Experimental Medicine|June 23, 2017
Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferationAdam J Mead, Wen Hao Neo, Nikolaos Barkas, et al.
The Journal of Experimental Medicine|January 8, 2021
Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemiaEleni Louka, Benjamin Povinelli, Alba Rodriguez-Meira, et al.
Cancer Cell|February 14, 2018
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic ProgenitorsChristopher A G Booth, Nikolaos Barkas, Wen Hao Neo, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2026
Protein <i>S</i> -acylation dynamics provide metabolic plasticity to acute myeloid leukemia cellsNithya Balasundaram, Ayşegül Erdem, Azeem Sharda, et al.
The American Journal of Surgical Pathology|April 20, 2026
The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid NeoplasmsSarah J Wu, Christopher B Hergott, Gabriel K Griffin, et al.
Cancer Discovery|December 18, 2016
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to VenetoclaxJoan Montero, Jason Stephansky, Tianyu Cai, et al.
The New England Journal of Medicine|April 25, 2019
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell NeoplasmNaveen Pemmaraju, Andrew A Lane, Kendra L Sweet, et al.
The Journal of Clinical Investigation|August 23, 2019
DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistanceKatsuhiro Togami, Timothy Pastika, Jason Stephansky, et al.
Pageof 10